5 matches for your search in the start-up spotlight
rss
Investments will support new product offerings, US expansion, and development of pathology foundation models
05-Nov-2024
Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced that it has raised $34 million in Series B financing. This additional funding will be used to build new product offerings for biopharmaceutical clients, ...
"Together with Bayer, we’re excited to transform AI’s immense potential into a reality for healthcare"
18-Mar-2024
Bayer and Aignostics GmbH announced a strategic collaboration on several artificial intelligence (AI)-powered approaches with applications in precision oncology drug research and development. Aignostics is a spin-off from one of the world’s leading hospitals, Charité-Universitätsmedizin Berlin, ...
Spin-off from Charité developing sophisticated AI models to improve understanding, diagnosis and treatment of complex diseases
19-Sep-2022
Aignostics, a spin-off from Charité – Universitätsmedizin Berlin, developing novel digital pathology solutions with “Explainable AI” for pharmaceutical research and diagnostics, today announced the closing of an oversubscribed €14m Series A financing round. Wellington Partners led the round, ...
Aignostics Raises €5 Million Seed Round
31-Aug-2020
Aignostics, a spin-off from Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) pioneering computational pathology for pharmaceutical research and diagnostics, has announced the closing of a €5 M seed round funding. Boehringer Ingelheim Venture Fund (BIVF) led the round, ...
BIH Digital Health Accelerator guides Aignostics GmbH through its spin-off
27-Apr-2020
The usual way to determine if a suspicious lump is cancerous involves microscopic examination in a pathology laboratory. To ease the workload of pathologists who face a rising number of cancer cases and increasingly finer molecular details and to enable tailored treatments, scientists at the ...
